Hill Happenings
Tracking the Hill's briefings, receptions, workshops, and more.
DSC_0170.JPG

List

Events

Tracking the Hill's briefings, luncheons, receptions, and more.
Filter by tags: Career Social | After 5 Food

Back to All Events

Bench to Bedside: Building from Neuroscience Research Discoveries:

  • 2045 Rayburn House Office Building (map)

Lunch Provided

 Dear Colleague, 

On behalf of the Congressional Neuroscience Caucus, I am reaching out to encourage you to attend a lunchtime briefing on Tuesday, January 29, 2019 at 12 noon entitled “Bench to Bedside: Building from Neuroscience Research Discoveries”. 

As you know, federal investments have played a critical role in supporting the foundational knowledge that makes translational and clinical research possible. Congress has increased funding for the NIH for the past four consecutive years. Of the $39.1 billion provided in FY2019, NIH estimates that it will be devoting more than $7 billion to neuroscience research. In addition, scientists are actively working to develop new tools as part of the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative. 

Speakers will discuss how efforts can build on these successes over the past few years. Additionally, they will describe the need to leverage increased federal funding with private investment to ensure that novel therapies are available to the people who most need them. 

Gabrielle Anwar, American actress and patient advocate, will share her experiences with depression/bipolar disorder and her perspectives of the treatment options available to her. 

Dr. Charles Nemeroff, Professor of Psychiatry at the University of Texas Dell Medical School in Austin, will provide information about preventing and treating mental health conditions associated with suicide.  

Leslie Ritter, Senior Director for Federal Government Relations at the National Multiple Sclerosis Society, will review the recent work of Congress to support neuroscience research and the remaining challenges the neuroscience community must tackle to get treatments into the hands of patients. 

We hope you will come learn more about this important issue in neuroscience. 

(This widely-attended event complies with all appropriate regulations.)Lunch Provided

 

Dear Colleague, 

On behalf of the Congressional Neuroscience Caucus, I am reaching out to encourage you to attend a lunchtime briefing on Tuesday, January 29, 2019 at 12 noon entitled “Bench to Bedside: Building from Neuroscience Research Discoveries”. 

As you know, federal investments have played a critical role in supporting the foundational knowledge that makes translational and clinical research possible. Congress has increased funding for the NIH for the past four consecutive years. Of the $39.1 billion provided in FY2019, NIH estimates that it will be devoting more than $7 billion to neuroscience research. In addition, scientists are actively working to develop new tools as part of the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative. 

Speakers will discuss how efforts can build on these successes over the past few years. Additionally, they will describe the need to leverage increased federal funding with private investment to ensure that novel therapies are available to the people who most need them. 

Gabrielle Anwar, American actress and patient advocate, will share her experiences with depression/bipolar disorder and her perspectives of the treatment options available to her. 

Dr. Charles Nemeroff, Professor of Psychiatry at the University of Texas Dell Medical School in Austin, will provide information about preventing and treating mental health conditions associated with suicide.  

Leslie Ritter, Senior Director for Federal Government Relations at the National Multiple Sclerosis Society, will review the recent work of Congress to support neuroscience research and the remaining challenges the neuroscience community must tackle to get treatments into the hands of patients. 

We hope you will come learn more about this important issue in neuroscience. 

(This widely-attended event complies with all appropriate regulations.)